NO20031396L - Derivater av tryptamin og analoge sammensetninger, og farmasoytiske formuleringer som inneholder disse - Google Patents

Derivater av tryptamin og analoge sammensetninger, og farmasoytiske formuleringer som inneholder disse

Info

Publication number: NO20031396L
Authority: NO; Norway
Prior art keywords: tryptamine; derivatives; pharmaceutical formulations; formulations containing; analogous compositions
Prior art date: 2000-10-03

Application number

NO20031396A

Other languages

English (en)

Other versions

NO20031396D0 (no

Inventor

Moshe Laudon

Nava Zisapel

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-03

Filing date

2003-03-27

Publication date

2003-03-27

2003-03-27 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

2003-03-27 Publication of NO20031396D0 publication Critical patent/NO20031396D0/no

2003-03-27 Publication of NO20031396L publication Critical patent/NO20031396L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Psychology (AREA)
Immunology (AREA)
Anesthesiology (AREA)
Toxicology (AREA)
Ophthalmology & Optometry (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20031396A 2000-10-03 2003-03-27 Derivater av tryptamin og analoge sammensetninger, og farmasoytiske formuleringer som inneholder disse NO20031396L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL138825A IL138825A (en)	2000-10-03	2000-10-03	Pharmaceutical preparations containing tryptamine derivatives and similar compounds, and such new compounds
PCT/IL2001/000898 WO2002028347A2 (en)	2000-10-03	2001-09-25	Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them

Publications (2)

Publication Number	Publication Date
NO20031396D0 NO20031396D0 (no)	2003-03-27
NO20031396L true NO20031396L (no)	2003-03-27

Family

ID=11074694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031396A NO20031396L (no)	2000-10-03	2003-03-27	Derivater av tryptamin og analoge sammensetninger, og farmasoytiske formuleringer som inneholder disse

Country Status (39)

Country	Link
US (2)	US6780884B2 (no)
EP (1)	EP1331935B1 (no)
JP (1)	JP2004533986A (no)
KR (1)	KR100855385B1 (no)
CN (1)	CN100518735C (no)
AR (1)	AR035587A1 (no)
AT (1)	ATE409474T1 (no)
AU (1)	AU9416201A (no)
BG (1)	BG107759A (no)
BR (1)	BR0114464A (no)
CA (1)	CA2423628C (no)
CL (1)	CL2001002303A1 (no)
CR (1)	CR6968A (no)
CY (1)	CY1110417T1 (no)
CZ (1)	CZ301098B6 (no)
DE (1)	DE60136003D1 (no)
DK (1)	DK1331935T3 (no)
EA (1)	EA005918B1 (no)
EE (1)	EE05192B1 (no)
ES (1)	ES2315307T3 (no)
GT (1)	GT200100197A (no)
HN (1)	HN2001000218A (no)
HU (1)	HU227163B1 (no)
IL (1)	IL138825A (no)
IS (1)	IS2607B (no)
MX (1)	MXPA03002612A (no)
NO (1)	NO20031396L (no)
NZ (1)	NZ525587A (no)
PA (1)	PA8529801A1 (no)
PE (1)	PE20020411A1 (no)
PL (1)	PL365679A1 (no)
PT (1)	PT1331935E (no)
SI (1)	SI1331935T1 (no)
SK (1)	SK4042003A3 (no)
TW (1)	TWI270544B (no)
UA (1)	UA75091C2 (no)
UY (1)	UY26946A1 (no)
WO (1)	WO2002028347A2 (no)
ZA (1)	ZA200303113B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050250794A1 (en) *	2003-12-19	2005-11-10	Andrew Napper	Methods of treating a disorder
CA2556753C (en) *	2004-02-20	2014-11-25	Lifescape Biosciences Incorporated	Compositions and methods for sleep regulation
CA2612979A1 (en) *	2005-06-10	2006-12-21	Bipar Sciences, Inc.	Parp modulators and treatment of cancer
US7622495B2 (en)	2006-10-03	2009-11-24	Neurim Pharmaceuticals (1991) Ltd.	Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
KR101760139B1 (ko)	2007-06-29	2017-07-31	클라렌슈 피티와이 리미티드	안투여를 통한 신경 또는 신경정신 장애의 치료 또는 예방용 약학 조성물
US8852630B2 (en)	2008-05-13	2014-10-07	Yale University	Chimeric small molecules for the recruitment of antibodies to cancer cells
EP2291659B1 (en) *	2008-05-13	2015-09-16	Yale University	Chimeric small molecules for the recruitment of antibodies to cancer cells
CN103841890B (zh)	2011-05-31	2017-10-27	克拉伦苏股份有限公司	预防和治疗运动相关神经系统疾病的方法
US9073851B2 (en)	2011-10-28	2015-07-07	Board Of Regents, The University Of Texas System	Compositions and methods for treating cancer
CN102816103B (zh) *	2012-08-20	2014-05-07	冉瑞琼	硫化天冬氨酸修饰的退黑素衍生物及其应用
SG11201807079UA (en) *	2016-03-14	2018-09-27	Somalogic Inc	Compounds and methods for the synthesis of 5-(n-protected-tryptaminocarboxyamide)-2'-deoxyuridine phosphoramidate for incorporation into a nucleic sequence
CN116421600B (zh) *	2023-05-29	2024-08-23	重庆医科大学	色醇在制备治疗焦虑的药物中的应用
WO2025137730A1 (en) *	2023-12-22	2025-06-26	Alexander Shulgin Research Institute, Inc.	N-substituted tryptamines and n-substituted lysergamides and their use as therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL79264A0 (en) *	1986-06-27	1986-09-30	Univ Ramot	Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
AUPO274596A0 (en) *	1996-10-04	1996-10-31	Armstrong, Stuart Maxwell	Method for the treatment of neurological or neuropsychiatric disorders
US6310085B1 (en) *	1997-10-03	2001-10-30	Clarencew Pty Ltd.	Method for the treatment of neurological or neuropsychiatric disorders

2000
- 2000-10-03 IL IL138825A patent/IL138825A/en not_active IP Right Cessation
2001
- 2001-09-14 TW TW090122940A patent/TWI270544B/zh not_active IP Right Cessation
- 2001-09-25 WO PCT/IL2001/000898 patent/WO2002028347A2/en not_active Ceased
- 2001-09-25 AU AU9416201A patent/AU9416201A/xx not_active Withdrawn
- 2001-09-25 UY UY26946A patent/UY26946A1/es not_active Application Discontinuation
- 2001-09-25 CN CNB018168043A patent/CN100518735C/zh not_active Expired - Fee Related
- 2001-09-25 EA EA200300436A patent/EA005918B1/ru not_active IP Right Cessation
- 2001-09-25 CZ CZ20030940A patent/CZ301098B6/cs not_active IP Right Cessation
- 2001-09-25 SI SI200130889T patent/SI1331935T1/sl unknown
- 2001-09-25 AR ARP010104520A patent/AR035587A1/es unknown
- 2001-09-25 CL CL2001002303A patent/CL2001002303A1/es unknown
- 2001-09-25 PT PT01974651T patent/PT1331935E/pt unknown
- 2001-09-25 AT AT01974651T patent/ATE409474T1/de active
- 2001-09-25 BR BR0114464-2A patent/BR0114464A/pt not_active Application Discontinuation
- 2001-09-25 MX MXPA03002612A patent/MXPA03002612A/es active IP Right Grant
- 2001-09-25 SK SK404-2003A patent/SK4042003A3/sk unknown
- 2001-09-25 EE EEP200300135A patent/EE05192B1/xx not_active IP Right Cessation
- 2001-09-25 JP JP2002531973A patent/JP2004533986A/ja active Pending
- 2001-09-25 ES ES01974651T patent/ES2315307T3/es not_active Expired - Lifetime
- 2001-09-25 DK DK01974651T patent/DK1331935T3/da active
- 2001-09-25 CA CA2423628A patent/CA2423628C/en not_active Expired - Fee Related
- 2001-09-25 EP EP01974651A patent/EP1331935B1/en not_active Expired - Lifetime
- 2001-09-25 NZ NZ525587A patent/NZ525587A/en unknown
- 2001-09-25 HU HU0302616A patent/HU227163B1/hu not_active IP Right Cessation
- 2001-09-25 US US10/381,976 patent/US6780884B2/en not_active Expired - Fee Related
- 2001-09-25 KR KR1020037004661A patent/KR100855385B1/ko not_active Expired - Fee Related
- 2001-09-25 PL PL01365679A patent/PL365679A1/xx not_active Application Discontinuation
- 2001-09-25 DE DE60136003T patent/DE60136003D1/de not_active Expired - Lifetime
- 2001-09-25 UA UA2003043421A patent/UA75091C2/uk unknown
- 2001-09-26 PE PE2001000960A patent/PE20020411A1/es not_active Application Discontinuation
- 2001-09-27 GT GT200100197A patent/GT200100197A/es unknown
- 2001-10-01 PA PA20018529801A patent/PA8529801A1/es unknown
- 2001-10-02 HN HN2001000218A patent/HN2001000218A/es unknown
2003
- 2003-03-21 IS IS6752A patent/IS2607B/is unknown
- 2003-03-27 NO NO20031396A patent/NO20031396L/no not_active Application Discontinuation
- 2003-04-23 ZA ZA200303113A patent/ZA200303113B/xx unknown
- 2003-04-24 BG BG107759A patent/BG107759A/bg unknown
- 2003-05-02 CR CR6968A patent/CR6968A/es unknown
2004
- 2004-08-20 US US10/921,823 patent/US20050020664A1/en not_active Abandoned
2008
- 2008-12-22 CY CY20081101480T patent/CY1110417T1/el unknown

Also Published As

Publication number	Publication date
NO20031396D0 (no)	2003-03-27
BG107759A (bg)	2004-01-30
DE60136003D1 (de)	2008-11-13
EE200300135A (et)	2003-08-15
EP1331935A4 (en)	2004-12-01
AU9416201A (en)	2002-04-15
JP2004533986A (ja)	2004-11-11
GT200100197A (es)	2002-05-08
EA200300436A1 (ru)	2003-10-30
TWI270544B (en)	2007-01-11
SI1331935T1 (sl)	2009-04-30
CN1582147A (zh)	2005-02-16
BR0114464A (pt)	2004-01-20
ZA200303113B (en)	2004-07-23
KR100855385B1 (ko)	2008-09-04
NZ525587A (en)	2005-03-24
EA005918B1 (ru)	2005-06-30
EP1331935A2 (en)	2003-08-06
CR6968A (es)	2004-02-25
UA75091C2 (en)	2006-03-15
CZ301098B6 (cs)	2009-11-04
PT1331935E (pt)	2009-01-19
WO2002028347A2 (en)	2002-04-11
CL2001002303A1 (es)	2010-06-25
PE20020411A1 (es)	2002-05-16
CN100518735C (zh)	2009-07-29
UY26946A1 (es)	2001-11-30
ES2315307T3 (es)	2009-04-01
CA2423628A1 (en)	2002-04-11
DK1331935T3 (da)	2009-02-02
HUP0302616A2 (hu)	2003-11-28
WO2002028347A3 (en)	2002-07-04
CY1110417T1 (el)	2015-04-29
PL365679A1 (en)	2005-01-10
KR20030051689A (ko)	2003-06-25
IS2607B (is)	2010-04-15
IL138825A (en)	2006-06-11
PA8529801A1 (es)	2002-12-30
HU227163B1 (en)	2010-09-28
IL138825A0 (en)	2001-10-31
EP1331935B1 (en)	2008-10-01
US6780884B2 (en)	2004-08-24
CA2423628C (en)	2011-04-26
EE05192B1 (et)	2009-08-17
US20050020664A1 (en)	2005-01-27
MXPA03002612A (es)	2004-04-02
ATE409474T1 (de)	2008-10-15
SK4042003A3 (en)	2003-09-11
HK1074163A1 (zh)	2005-11-04
US20040029950A1 (en)	2004-02-12
HN2001000218A (es)	2002-05-09
CZ2003940A3 (cs)	2003-10-15
AR035587A1 (es)	2004-06-16
IS6752A (is)	2003-03-21

Publication	Publication Date	Title
HUP0401503A3 (en)	2009-06-29	Indole, azaindole and related heterocyclic aminopiperazine derivatives and pharmaceutical compositions containing them
NO20020687L (no)	2002-04-03	3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
DK1202965T3 (da)	2005-02-14	Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
IS7735A (is)	2005-03-10	Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær.
HUP0400467A3 (en)	2012-08-28	2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
IL192937A0 (en)	2009-02-11	Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same
IL154965A0 (en)	2003-10-31	Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
IL162547A0 (en)	2005-11-20	Fused heterocyclic succinimide derivatives and pharmaceutical compositions containing the same
IL161582A0 (en)	2004-09-27	Use of oxindole hydrazide derivatives for the preparation of pharmaceutical compositions, certain such new derivatives and their preparation
DK1095020T3 (da)	2006-01-16	2-Aminopyridinderivater, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem
HUP0500024A3 (en)	2009-01-28	6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
NO20031396L (no)	2003-03-27	Derivater av tryptamin og analoge sammensetninger, og farmasoytiske formuleringer som inneholder disse
DK1495023T3 (da)	2005-12-27	Hidtil ukendte derivater af 1,2,3-substitueret indolizin, FGF-inhibitorer, fremgangsmåde for fremstilling og farmaceutiske sammensætninger indeholdende disse
NO20015659D0 (no)	2001-11-20	Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse
DK1560826T3 (da)	2006-08-14	Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
PL356911A1 (en)	2004-07-12	Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
NO20016404L (no)	2002-03-01	Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
HUP0201338A2 (en)	2002-10-28	Novel indole derivatives, pharmaceutical compositions containing them and their use
IL154966A0 (en)	2003-10-31	Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
IS2315B (is)	2007-11-15	Nýjar greinóttar setnar amínó afleiður af 3-amínó-1-fenýl-1H[1,2,4]tríasóli, aðferðir til framleiðslu á þeim og lyfjasamsetningar sem innihalda þær
HUP0203767A3 (en)	2004-06-28	Novel indole derivatives, pharmaceutical compositions containing them and their use
DK1215213T3 (da)	2007-05-21	Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse
DK1275647T3 (da)	2004-03-15	Octahydro-1H-pyrido[1,2-a]pyrazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1171444T3 (da)	2003-10-27	Pyridothienodiazepiner, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
DK1263719T3 (da)	2009-11-16	N-deacetylthiocolchin-derivater og farmaceutiske sammensætninger indeholdende disse.

Legal Events

Date	Code	Title	Description
2011-09-19	FC2A	Withdrawal, rejection or dismissal of laid open patent application